The Legal Implications of 3D Printed Guns

3D Printed Guns and The Law Recently, 3D printing has become the center of an ongoing legal controversy.  As the law struggles to catch up with technology, there has been much debate about which legal rights, if any, apply to the possession of the blueprints for these weapons and of the weapons themselves. How does 3D printing work? 3D printing was invented earlier than most people think. In 1983, Chuck Hull worked for a local Continue Reading →

STLR Link Roundup – November 30, 2019

DJ Khaled and Floyd Mayweather Settle I.C.O. Case On Thursday, November 29, the Securities and Exchange Commission announced that the boxer Floyd Mayweather Jr. and producer DJ Khaled would pay significant sums to settle charges that they illegally promoted investments in an unregulated cryptocurrency offering. The founders of Centra Tech, a virtual currency startup, were arrested in May and charged with defrauding investors. Centra had enlisted Mayweather and Khaled to help promote the company’s initial Continue Reading →

STLR Link Roundup – November 23, 2018

Apple to Defend its App Store On Monday, November 26, Apple will go in front of the Supreme Court in the case Pepper v. Apple Inc. It will be defending its business model that all apps on its iOS mobile operating system be sold through its own App Store. In short, Apple will be arguing that its App Store is not running as a monopoly violating antitrust laws. Amazon Announces New Headquarters Amazon has selected Northern Virginia Continue Reading →

The Legality of Law Enforcement’s Access to Genetic Testing Profiles without a Court Order

Researchers in the last century have made huge strides in the biological sciences. From the discovery of the double helix of deoxyribonucleic acid (DNA) in 1953, to the completion of the Human Genome Project by the National Human Genome Research Institute fifty years later, researchers have continued to make significant technological and scientific breakthroughs. Genetic testing, a medical test that can determine whether a person has, may develop or can pass on a genetic condition, Continue Reading →

STLR Link Roundup – November 16, 2018

SEC Settles Charges Against Two Companies for Initial Coin Offerings On November 16, 2018, the SEC settled charges against cryptocurrency firms Paragon Coin Inc. and CarrierEQ Inc. (Airfox) for selling unregistered securities tokens. Under the terms of the settlement, both firms agreed to pay $250,000 in civil penalties and undertake efforts to compensate investors who purchased the illegally offered tokens. Paragon and Airfox must also prepare an initial disclosure within 90 days and file periodic Continue Reading →

USPTO’s Patent Trial and Appeal Board Moves to Phillips Standard

Background On October 11, 2018 the United States Patent and Trademark Office (USPTO) adopted a final rule that changed the standard of claim construction in the Patent Trial and Appeal Board (PTAB) to the standard used in district court as articulated in Phillips v. AWH Corp., 415 F.3d 1303 (Fed. Cir. 2005) (en banc). The PTAB is the adjudicatory body of the USPTO that hears appeals regarding rejected patents and conducts trials regarding validity of Continue Reading →

STLR Link Roundup – November 12, 2018

SCOTUS to Decide Whether the U.S. Government Is a “Person” Who may Petition to Institute Review Proceedings Under the AIA The Supreme Court of the United States, on October 26, 2018, granted certiorari in Return Mail Inc. v. United States Postal Service, to address Question 1 of the petition: whether the U.S. government is a “person” who may petition for AIA review of issued patents without facing the estoppel consequences that apply to private parties.  Continue Reading →

The Future of Personalized Medicine: How Should Genomic Sequencing Be Regulated?

Background Healthcare is currently making a historic transition towards personalized medicine, a new and emerging healthcare model for treatment and prevention strategies tailored towards the client’s specific genetic variation, lifestyle, and environment. Among the tools used in this model, genomic sequencing is one that is quintessential to the creation and effectiveness of these strategic plans. Breakthroughs in science and technology allow laboratories to sequence an entire human genome within 24 hours and at a reasonably Continue Reading →

STLR Link Roundup – November 2, 2018

No Crypto ETF from BlackRock Anytime Soon, CEO Says The largest asset manager in the world, BlackRock, won’t be launching a bitcoin ETF until cryptocurrencies are seen as legitimate, according to BlackRock CEO Larry Fink. Fink does say, however, that he could see the day where there is electronic trading for crypto that could be a store of wealth. The SEC also has doubts about a bitcoin ETF, and has yet to approve any application for such Continue Reading →

HHS and Treasury Issue New Guidance on PPACA Waivers

On Monday, October 22, 2018 the Departments of Health and Human Services (HHS) and the Treasury issued new guidance pertaining to state waivers under Section 1332 of the Patient Protection and Affordable Care Act (PPACA). Section 1332 waivers (formerly “State Innovation Waivers” and now “State Relief and Empowerment Waivers”) allow states to apply for waivers for specific ACA health care plan requirements. Under the terms of the PPACA, the HHS Secretary can request waivers only Continue Reading →